IGF1 and non-small cell lung carcinoma: For example, recent studies have identified the role of the IGF axis and of dysregulation of downstream signaling molecules, including PI-3K/Akt and MAPK pathways, reporting that they jointly increase the risk of growth, invasion and metastasis in NSCLC (48, 52).